102

#9 - 4-27-11 Version-David Caraway

  • Upload
    others

  • View
    7

  • Download
    0

Embed Size (px)

Citation preview

Page 1: #9 - 4-27-11 Version-David Caraway
Page 2: #9 - 4-27-11 Version-David Caraway
Page 3: #9 - 4-27-11 Version-David Caraway
Page 4: #9 - 4-27-11 Version-David Caraway
Page 5: #9 - 4-27-11 Version-David Caraway
Page 6: #9 - 4-27-11 Version-David Caraway
Page 7: #9 - 4-27-11 Version-David Caraway
Page 8: #9 - 4-27-11 Version-David Caraway
Page 9: #9 - 4-27-11 Version-David Caraway
Page 10: #9 - 4-27-11 Version-David Caraway
Page 11: #9 - 4-27-11 Version-David Caraway
Page 12: #9 - 4-27-11 Version-David Caraway
Page 13: #9 - 4-27-11 Version-David Caraway
Page 14: #9 - 4-27-11 Version-David Caraway
Page 15: #9 - 4-27-11 Version-David Caraway
Page 16: #9 - 4-27-11 Version-David Caraway
Page 17: #9 - 4-27-11 Version-David Caraway
Page 18: #9 - 4-27-11 Version-David Caraway
Page 19: #9 - 4-27-11 Version-David Caraway
Page 20: #9 - 4-27-11 Version-David Caraway

Are supplemental systemic opioids

necessary?

• No Pharmacological rationale for multiple routes of delivery

• Defeats the advantages of intrathecal route of delivery

• Methylnaltrexone data in treatment of opioid induced constipation (OIC)1

• Blockade of peripheral mu receptors does not:

–change pain scores

–induce withdrawal

–increase opioid requirements

1. Slatkin N, Thomas J, Lipman AG. Methylnaltrexone for treatment

of opiod-induced constipation in advanced illness patients. J

Support Oncol. 2009 Jan-Feb;7(1):39-46

Page 21: #9 - 4-27-11 Version-David Caraway
Page 22: #9 - 4-27-11 Version-David Caraway
Page 23: #9 - 4-27-11 Version-David Caraway
Page 24: #9 - 4-27-11 Version-David Caraway
Page 25: #9 - 4-27-11 Version-David Caraway
Page 26: #9 - 4-27-11 Version-David Caraway
Page 27: #9 - 4-27-11 Version-David Caraway
Page 28: #9 - 4-27-11 Version-David Caraway
Page 29: #9 - 4-27-11 Version-David Caraway
Page 30: #9 - 4-27-11 Version-David Caraway
Page 31: #9 - 4-27-11 Version-David Caraway
Page 32: #9 - 4-27-11 Version-David Caraway
Page 33: #9 - 4-27-11 Version-David Caraway
Page 34: #9 - 4-27-11 Version-David Caraway
Page 35: #9 - 4-27-11 Version-David Caraway
Page 36: #9 - 4-27-11 Version-David Caraway
Page 37: #9 - 4-27-11 Version-David Caraway
Page 38: #9 - 4-27-11 Version-David Caraway
Page 39: #9 - 4-27-11 Version-David Caraway
Page 40: #9 - 4-27-11 Version-David Caraway
Page 41: #9 - 4-27-11 Version-David Caraway
Page 42: #9 - 4-27-11 Version-David Caraway
Page 43: #9 - 4-27-11 Version-David Caraway

Transforaminal Epidural InjectionsEvidence for transforaminal epidural steroid injections based

on all available high level studies (1):

1. Strong for short term management of lumbar nerve root pain

2. Moderate for long term management

3. Limited in managing axial low back pain

4. European Guidelines also provide favorable evidence for

use of TEESI (2)

1. Pain Physician: January 2007, 10: 7-111 2. Ear Spine J,15S192-S300

Page 44: #9 - 4-27-11 Version-David Caraway
Page 45: #9 - 4-27-11 Version-David Caraway
Page 46: #9 - 4-27-11 Version-David Caraway
Page 47: #9 - 4-27-11 Version-David Caraway
Page 48: #9 - 4-27-11 Version-David Caraway
Page 49: #9 - 4-27-11 Version-David Caraway
Page 50: #9 - 4-27-11 Version-David Caraway
Page 51: #9 - 4-27-11 Version-David Caraway
Page 52: #9 - 4-27-11 Version-David Caraway
Page 53: #9 - 4-27-11 Version-David Caraway
Page 54: #9 - 4-27-11 Version-David Caraway
Page 55: #9 - 4-27-11 Version-David Caraway
Page 56: #9 - 4-27-11 Version-David Caraway
Page 57: #9 - 4-27-11 Version-David Caraway
Page 58: #9 - 4-27-11 Version-David Caraway
Page 59: #9 - 4-27-11 Version-David Caraway
Page 60: #9 - 4-27-11 Version-David Caraway
Page 61: #9 - 4-27-11 Version-David Caraway
Page 62: #9 - 4-27-11 Version-David Caraway
Page 63: #9 - 4-27-11 Version-David Caraway
Page 64: #9 - 4-27-11 Version-David Caraway
Page 65: #9 - 4-27-11 Version-David Caraway
Page 66: #9 - 4-27-11 Version-David Caraway
Page 67: #9 - 4-27-11 Version-David Caraway
Page 68: #9 - 4-27-11 Version-David Caraway
Page 69: #9 - 4-27-11 Version-David Caraway
Page 70: #9 - 4-27-11 Version-David Caraway
Page 71: #9 - 4-27-11 Version-David Caraway
Page 72: #9 - 4-27-11 Version-David Caraway
Page 73: #9 - 4-27-11 Version-David Caraway
Page 74: #9 - 4-27-11 Version-David Caraway
Page 75: #9 - 4-27-11 Version-David Caraway
Page 76: #9 - 4-27-11 Version-David Caraway
Page 77: #9 - 4-27-11 Version-David Caraway
Page 78: #9 - 4-27-11 Version-David Caraway
Page 79: #9 - 4-27-11 Version-David Caraway
Page 80: #9 - 4-27-11 Version-David Caraway
Page 81: #9 - 4-27-11 Version-David Caraway
Page 82: #9 - 4-27-11 Version-David Caraway
Page 83: #9 - 4-27-11 Version-David Caraway
Page 84: #9 - 4-27-11 Version-David Caraway
Page 85: #9 - 4-27-11 Version-David Caraway
Page 86: #9 - 4-27-11 Version-David Caraway
Page 87: #9 - 4-27-11 Version-David Caraway
Page 88: #9 - 4-27-11 Version-David Caraway
Page 89: #9 - 4-27-11 Version-David Caraway
Page 90: #9 - 4-27-11 Version-David Caraway
Page 91: #9 - 4-27-11 Version-David Caraway
Page 92: #9 - 4-27-11 Version-David Caraway
Page 93: #9 - 4-27-11 Version-David Caraway
Page 94: #9 - 4-27-11 Version-David Caraway
Page 95: #9 - 4-27-11 Version-David Caraway
Page 96: #9 - 4-27-11 Version-David Caraway
Page 97: #9 - 4-27-11 Version-David Caraway
Page 98: #9 - 4-27-11 Version-David Caraway
Page 99: #9 - 4-27-11 Version-David Caraway
Page 100: #9 - 4-27-11 Version-David Caraway
Page 101: #9 - 4-27-11 Version-David Caraway
Page 102: #9 - 4-27-11 Version-David Caraway